CLGN
CollPlant Biotechnologies Ltd - Ordinary Shares New

596
Mkt Cap
$27.21M
Volume
7,402.00
52W High
$4.98
52W Low
$1.31
PE Ratio
-1.90
CLGN Fundamentals
Price
$2.14
Prev Close
$2.14
Open
$2.11
50D MA
$2.36
Beta
0.12
Avg. Volume
44,765.17
EPS (Annual)
-$1.45
P/B
2.18
Rev/Employee
$9,035.09
Loading...
Loading...
News
all
press releases
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS PR Newswire REHOVOT, Israel, Nov...
PR Newswire·2d ago
News Placeholder
More News
News Placeholder
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada PR Newswire...
PR Newswire·25d ago
News Placeholder
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk First-in-Kind Fully Humanized 3D Bioprinted Human Skin...
PR Newswire·1mo ago
News Placeholder
CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia
CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia PR Newswire REHOVOT, Israel, Feb. 24, 2025...
PR Newswire·9mo ago
News Placeholder
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND...
PR Newswire·1y ago
News Placeholder
CollPlant, Stratasys Initiate Study for Breast Implants
CollPlant Biotechnologies (NASDAQ: CLGN) and Stratasys Ltd. read more...
Benzinga·1y ago
News Placeholder
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies
Latest Ratings for CLGN DateFirmActionFromTo Feb 2021HC Wainwright & Co.MaintainsBuy May 2020HC Wainwright & Co.ReiteratesBuy Apr 2020HC Wainwright & Co.ReiteratesBuy View More Analyst Ratings...
Benzinga·1y ago
News Placeholder
CollPlant Announces Upcoming Shareholder Meeting
Collplant Holdings (CLGN) has released an update. CollPlant Biotechnologies Ltd. has announced its annual and extraordinary general meeting for sha...
TipRanks Financial Blog·1y ago
News Placeholder
CollPlant Pursues $3B Market with 3D-Printed Implants
Collplant Holdings (CLGN) has released an update. CollPlant Biotechnologies has initiated pre-clinical trials of 200cc regenerative breast implants...
TipRanks Financial Blog·1y ago
News Placeholder
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE...
PR Newswire·1y ago

Latest CLGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.